Inactive Instrument

EPS Holdings, Inc.

Equities

4282

JP3130770005

Biotechnology & Medical Research

Suzuken Co., Ltd. agreed to acquire 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc.

December 23, 2021

Suzuken Co., Ltd. (TSE:9987) agreed to acquire 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc. on December 24, 2021. Suzuken will acquire 40,861 shares of EP-PharmaLine. EP-PharmaLine reported sales of ¥9.6 billion for the fiscal year ended September 2021.

Schedule date of conclusion of share transfer agreement is December 24, 2021, and transaction is expected to complete in mid-January 2022.

Latest news about EPS Holdings, Inc.

GNI Group Ltd. forms joint venture with EPS in Japan focusing on medical device business	22-10-07	CI
MedPeer,Inc. completed the acquisition of Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others.	22-10-02	CI
MedPeer,Inc. announced that it has received ¥306.9 million in funding from EPS Holdings, Inc.	22-10-02	CI
MedPeer,Inc. entered into an agreement to acquire Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others for Ã‘5000 million.	22-08-08	CI
MedPeer,Inc. announced that it expects to receive Ã‘306.9 million in funding from EPS Holdings, Inc.	22-08-08	CI
Suzuken Co., Ltd. completed the acquisition of 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc.	22-03-30	CI
Suzuken Co., Ltd. agreed to acquire 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc.	21-12-23	CI
EPS Holdings, Inc.(TSE:4282) dropped from S&P Global BMI Index	21-09-07	CI
Speed Apparel : EPS Creative Setting Up $2 Million Startup Fund	21-08-31	MT
Y&G Limited completed the acquisition of additional 65.7% stake in EPS Holdings, Inc. from Suzuken Co., Ltd., Medical System Network Co., Ltd. and others for ¥ 53.4 billion.	21-07-07	CI
Speed Apparel : Restores Public Float to 25%	21-06-18	MT
Speed Apparel : EPS Closes Mandatory Takeover Bid for Speed Apparel	21-06-17	MT
Y&G Limited made an offer to acquire remaining 78% stake in EPS Holdings, Inc. from Suzuken Co., Ltd., Medical System Network Co., Ltd. and others for ¥62.2 billion.	21-05-26	CI
Speed Apparel : Japan's EPS Buys Controlling Stake in Hong Kong's Speed Apparel Under Smart Wear Push	21-05-06	MT
EPS Holdings, Inc. made a mandatory offer to acquire remaining 25% stake in Speed Apparel Holding Limited for approximately HKD 120 million.	21-05-04	CI
EPS Holdings, Inc. acquired 75% stake in Speed Apparel Holding Limited from Speed Development Co. Ltd. for approximately HKD 370 million.	21-04-25	CI
Tranche Update on EPS Holdings, Inc.'s Equity Buyback Plan announced on March 18, 2020.	20-12-18	CI
EPS Holdings, Inc.'s Equity Buyback announced on March 18, 2020 has expired with 1,593,900 shares, representing 3.52% for ¥1,690.04 million.	20-12-16	CI
Hong Kong Tigermed Technology Co., Ltd. cancelled the acquisition of 3.06% stake in EPS Holdings, Inc..	20-10-29	CI
Tranche Update on EPS Holdings, Inc.'s Equity Buyback Plan announced on March 18, 2020.	20-10-01	CI
Xenoma, Inc. announced that it has received funding from EPS Holdings, Inc., Ono Pharmaceutical Co., Ltd.	20-09-10	CI
Tranche Update on EPS Holdings, Inc.'s Equity Buyback Plan announced on March 18, 2020.	20-07-01	CI
Tranche Update on EPS Holdings, Inc.'s Equity Buyback Plan announced on March 18, 2020.	20-04-01	CI
EPS Holdings, Inc. announces an Equity Buyback for 2,300,000 shares, representing 5.02% for ¥2,500 million.	20-03-18	CI
EPS Holdings, Inc. authorizes a Buyback Plan.	20-03-17	CI

Chart EPS Holdings, Inc.

Duration

Period

More charts

Company Profile

EPS Holdings, Inc., formerly EPS Corporation, mainly offers medical-related services. Contract Research Organization (CRO) segment provides clinical trials operating and management-related services. Site Management Organization (SMO) segment offers clinical research coordinators (CRCs) to medical institutions. Contract Research Organization (CSO) segment provides drug information and awareness advertisement reception service to medical and pharmaceutical, healthcare industries. Pharmaceutical and Medical Information Technology-related segment is engaged in the development and support service of systems used for clinical trials.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research